Plasma amyloid-β biomarkers are associated with Alzheimer′s disease comorbidity in Lewy body disease

被引:1
|
作者
Noguchi-Shinohara, Moeko [1 ]
Murakami, Hidetomo [2 ]
Sakashita, Yasuhiro [1 ]
Mori, Yukiko [2 ]
Komatsu, Junji [1 ,3 ]
Muramatsu, Daiki [1 ]
Hikishima, Sadao [1 ]
Ono, Kenjiro [1 ]
机构
[1] Kanazawa Univ, Dept Neurol, Grad Sch Med Sci, 13-1 Takara Machi, Kanazawa 9208640, Japan
[2] Showa Univ, Sch Med, Dept Neurol, Tokyo, Japan
[3] Kanazawa Univ, Dept Preempt Med Dementia, Grad Sch Med Sci, Kanazawa, Japan
关键词
Lewy body disease; Plasma amyloid-ss; Alzheimer pathology;
D O I
10.1016/j.parkreldis.2023.105445
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
No blood biomarkers which can identify Alzheimer's disease pathology in Lewy body disease (LBD) have ever been established. We showed that the plasma amyloid-ss (A ss) (1-42)/A ss(1- 40) ratio was significantly decreased in patients with A ss+ LBD compared with those with A ss- LBD and it might be a useful biomarker.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Metals and amyloid-β in Alzheimer's disease
    Maynard, CJ
    Bush, AI
    Masters, CL
    Cappai, R
    Li, QX
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : 147 - 159
  • [22] Alzheimer's Disease and the Amyloid-β Peptide
    Murphy, M. Paul
    LeVine, Harry, III
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 311 - 323
  • [23] Amyloid-β immunisation for Alzheimer's disease
    Wisniewski, Thomas
    Konietzko, Uwe
    LANCET NEUROLOGY, 2008, 7 (09): : 805 - 811
  • [24] Intracellular amyloid-β in Alzheimer's disease
    Frank M. LaFerla
    Kim N. Green
    Salvatore Oddo
    Nature Reviews Neuroscience, 2007, 8 : 499 - 509
  • [25] Autoantibodies to amyloid-β and Alzheimer's disease
    Hyman, BT
    Smith, C
    Buldyrev, I
    Whelan, C
    Brown, H
    Tang, MX
    Mayeux, R
    ANNALS OF NEUROLOGY, 2001, 49 (06) : 808 - 810
  • [26] Presenilins, amyloid-β and Alzheimer's disease
    Bruce T. Lamb
    Nature Medicine, 1997, 3 : 28 - 29
  • [27] Metal-associated amyloid-β species in Alzheimer's disease
    Pithadia, Amit S.
    Lim, Mi Hee
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2012, 16 (1-2) : 67 - 73
  • [28] Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
    Young Chul Youn
    Sungmin Kang
    Jeewon Suh
    Young Ho Park
    Min Ju Kang
    Jung-Min Pyun
    Seong Hye Choi
    Jee Hyang Jeong
    Kyung Won Park
    Ho-Won Lee
    Seong Soo A. An
    Jacqueline C. Dominguez
    SangYun Kim
    Alzheimer's Research & Therapy, 11
  • [29] Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies
    Diaz-Galvan, Patricia
    Przybelski, Scott A.
    Algeciras-Schimnich, Alicia
    Figdore, Dan J.
    Lesnick, Timothy G.
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    Jack, Clifford R., Jr.
    Hmin, Paul
    Jain, Manoj K.
    Miyagawa, Toji
    Forsberg, Leah K.
    Fields, Julie A.
    Savica, Rodolfo
    Graff-Radford, Jonathan
    Ramanan, Vijay K.
    Jones, David T.
    Botha, Hugo
    St Louis, Erik K.
    Knopman, David S.
    Graff-Radford, Neill R.
    Ferman, Tanis J.
    Petersen, Ronald C.
    Lowe, Val J.
    Boeve, Bradley F.
    Kantarci, Kejal
    ALZHEIMERS & DEMENTIA, 2024, 20 (04) : 2485 - 2496
  • [30] Blood amyloid- oligomerization associated with neurodegeneration of Alzheimer's disease
    Youn, Young Chul
    Kang, Sungmin
    Suh, Jeewon
    Park, Young Ho
    Kang, Min Ju
    Pyun, Jung-Min
    Choi, Seong Hye
    Jeong, Jee Hyang
    Park, Kyung Won
    Lee, Ho-Won
    An, Seong Soo A.
    Dominguez, Jacqueline C.
    Kim, SangYun
    ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (1)